The synthesis of 20-HETE in small porcine coronary arteries antagonizes EDHF-mediated relaxation

Cardiovascular Research

Volumn 65, Issue 2, 2005, Pages 487-494

  Randriamboavonjy, Voahanginirina ^a   Kiss, Ladislau ^b   Falck, John R ^c   Busse, Rudi ^a   Fleming, Ingrid ^a  

^a GOETHE UNIVERSITY   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Endothelial factors; Na K pump; Protein kinase C; Stretch m e coupling; Vasoconstriction dilation

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 17 OCTADECYNOIC ACID; 2 (4 AMYLCINNAMIDO) 4 CHLOROBENZOIC ACID; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 20 HYDROXYICOSATETRAENOIC ACID; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALKANE 1 MONOOXYGENASE; ARACHIDONYL TRIFLUOROMETHYL KETONE; BROMINE DERIVATIVE; CLOTRIMAZOLE; CYTOCHROME P450 2C; CYTOCHROME P450 4A; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ENZYME INHIBITOR; MICONAZOLE; N METHYLSULFONYL 12,12 DIBROMODODEC 11 ENAMIDE; OUABAIN; PHOSPHOLIPASE A2 INHIBITOR; PROTEIN INHIBITOR; PROTEIN KINASE C ALPHA; SULFAPHENAZOLE; THROMBOXANE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CORONARY ARTERY; ENZYME PHOSPHORYLATION; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; AMIDES; ANIMALS; ARYL HYDROCARBON HYDROXYLASES; BIOLOGICAL FACTORS; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROXYEICOSATETRAENOIC ACIDS; MIXED FUNCTION OXYGENASES; PROTEIN KINASE C; SULFONES; SWINE; TETRADECANOYLPHORBOL ACETATE; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 11444267637     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.10.029     Document Type: Article

References (39)

1. K. Kauser, J.E. Clark, B.S. Masters, P.R. Ortiz de Montellano, Y.H. Ma, and D.R. Harder Inhibitors of cytochrome P-450 attenuate the myogenic response of dog renal arcuate arteries Circ. Res. 68 1991 1154 1163
2. Y.H. Ma, D. Gebremedhin, M.L. Schwartzman, J.R. Falck, J.E. Clark, and B.S. Masters 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries Circ. Res. 72 1993 126 136
3. A.P. Zou, J.D. Imig, M. Kaldunski, P.R. Ortiz de Montellano, Z. Sui, and R.J. Roman Inhibition of renal vascular 20-HETE production impairs autoregulation of renal blood flow Am. J. Physiol. 266 1994 F275 F282
4. D. Gebremedhin, A.R. Lange, T.F. Lowry, M.R. Taheri, E.K. Birks, and A.G. Hudetz Production of 20-HETE and its role in autoregulation of cerebral blood flow Circ. Res. 87 2000 60 65
5. D.R. Harder, D. Gebremedhin, J. Narayanan, C. Jefcoat, J.R. Falck, and W.B. Campbell Formation and action of a P-450 4A metabolite of arachidonic acid in cat cerebral microvessels Am. J. Physiol. 266 1994 H2098 H2107
6. D.R. Harder, W.B. Campbell, and R.J. Roman Role of cytochrome P-450 enzymes and metbolites of arachidonic acid in the control of vascular tone J. Vasc. Res. 32 1995 79 92
7. D.R. Harder, A.R. Lange, D. Gebremedhin, E.K. Birks, and R.J. Roman Cytochrome P450 metabolites of arachidonic acid as intracellular signaling molecules in vascular tissue J. Vasc. Res. 34 1997 237 243
8. R.J. Roman P-450 metabolites of arachidonic acid in the control of cardiovascular function Physiol. Rev. 82 2002 131 185
9. A. Lange, D. Gebremedhin, J. Narayanan, and D.R. Harder 20-Hydroxyeicosatetraenoic acid-induced vasoconstriction and inhibition of potassium current in cerebral vascular smooth muscle is dependent on activation of protein kinase C J. Biol. Chem. 272 1997 27345 27352
10. M. Ominato, T. Satoh, and A.I. Katz Regulation of Na-K-ATPase activity in the proximal tubule: role of the protein kinase C pathway and of eicosanoids J. Membr. Biol. 152 1996 235 243
11. + ATPase J. Clin. Invest. 99 1997 1224 1230
12. V. Randriamboavonjy, R. Busse, and I. Fleming 20-HETE-induced contraction of small coronary arteries depends on the activation of Rho-kinase Hypertension 41 2003 801 806
13. B. Lopez, C. Moreno, M.G. Salom, R.J. Roman, and F.J. Fenoy Role of guanylyl cyclase and cytochrome P-450 on renal response to nitric oxide Am. J. Physiol. Renal. Physiol. 281 2001 F420 F427
14. M. Alonso-Galicia, H.A. Drummond, K.K. Reddy, J.R. Falck, and R.J. Roman Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide Hypertension 29 1997 320 325
15. C.W. Sun, J.R. Falck, H. Okamoto, D.R. Harder, and R.J. Roman Role of cGMP versus 20-HETE in the vasodilator response to nitric oxide in rat cerebral arteries Am. J. Physiol., Heart Circ. Physiol. 279 2000 H339 H350
16. M.H. Wang, J. Wang, H.H. Chang, B.A. Zand, M. Jiang, and A. Nasjletti Regulation of renal CYP4A expression and 20-HETE synthesis by nitric oxide in pregnant rats Am. J. Physiol. Renal. Physiol. 285 2003 F295 F302
17. M.H. Wang, E. Brand-Schieber, B.A. Zand, X. Nguyen, J.R. Falck, and N. Balu Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors J. Pharmacol. Exp. Ther. 284 1998 966 973
18. 2+-independent activation of the endothelial nitric oxide synthase in response to tyrosine phosphatase inhibitors and fluid shear stress Circ. Res. 82 1998 686 695
19. L. Kiss, E. Bieniek, N. Weissmann, H. Schutte, U. Sibelius, and A. Gunther Simultaneous analysis of 4- and 5-series lipoxygenase and cytochrome P450 products from different biological sources by reversed-phase high-performance liquid chromatographic technique Anal. Biochem. 261 1998 16 28
20. B. Fisslthaler, R. Popp, L. Kiss, M. Potente, D.R. Harder, and I. Fleming Cytochrome P450 2C is an EDHF synthase in coronary arteries Nature 401 1999 493 497
21. E.C. Dempsey, A.C. Newton, D. Mochly-Rosen, A.P. Fields, M.E. Reyland, and P.A. Insel Protein kinase C isozymes and the regulation of diverse cell responses Am. J. Physiol., Lung Cell Mol. Physiol. 279 2000 L429 L438
22. +-ATPase J. Clin. Invest. 99 1997 1224 1230
23. Ca channel Br. J. Pharmacol. 137 2002 1362 1370
24. R. Busse, G. Edwards, M. Feletou, I. Fleming, P.M. Vanhoutte, and A.H. Weston EDHF: bringing the concepts together Trends Pharmacol. Sci. 23 2002 374 380
25. + is an endothelium-derived hyperpolarizing factor in rat arteries Nature 396 1998 269 272
26. T. Yada, H. Shimokawa, O. Hiramatsu, T. Kajita, F. Shigeto, and M. Goto Hydrogen peroxide, an endogenous endothelium-derived hyperpolarizing factor, plays an important role in coronary autoregulation in vivo Circulation 107 2003 1040 1045
27. W.B. Campbell, D. Gebremedhin, P.F. Pratt, and D.R. Harder Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors Circ. Res. 78 1996 415 423
28. Ca channels Circulation 107 2003 769 776
29. B. Fisslthaler, N. Hinsch, T. Chataigneau, R. Popp, L. Kiss, and R. Busse Nifedipine increases cytochrome P4502C expression and EDHF-mediated responses in coronary arteries Hypertension 36 2000 270 275
30. K.M. Gauthier, C. Deeter, U.M. Krishna, Y.K. Reddy, M. Bondlela, and J.R. Falck 14,15-Epoxyeicosa-5(Z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries Circ. Res. 90 2002 1028 1036
31. E. Büssemaker, C. Wallner, B. Fisslthaler, and I. Fleming The Na-K-ATPase is a target for an EDHF displaying characteristics similar to potassium ions in the porcine renal interlobar artery Br. J. Pharmacol. 137 2002 647 654
32. E. Büssemaker, R. Popp, J. Binder, R. Busse, and I. Fleming Characterization of the endothelium-derived hyperpolarizing factor (EDHF) response in the human interlobar artery Kidney Int. 63 2003 1749 1755
33. M.H. Wang, E. Brand-Schieber, B.A. Zand, X. Nguyen, J.R. Falck, and N. Balu Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors J. Pharmacol. Exp. Ther. 284 1998 966 973
34. R.J. Roman, K.G. Maier, C.W. Sun, D.R. Harder, and M. Alonso-Galicia Renal and cardiovascular actions of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids Clin. Exp. Pharmacol. Physiol. 27 2000 855 865
35. Ca channels Hypertension 41 2003 912 918
36. M. Alonso-Galicia, C.-W. Sun, J.R. Falck, D.R. Harder, and R.J. Roman Contribution of 20-HETE to the vasodilator actions of nitric oxide in renal arteries Am. J. Physiol. 275 1998 F370 F378
37. 2+-independent activation of the endothelial nitric oxide synthase Proc. Natl. Acad. Sci. U. S. A. 96 1999 1123 1128
38. J.D. Imig, B.T. Pham, E.A. LeBlanc, K.M. Reddy, J.R. Falck, and E.W. Inscho Cytochrome P450 and cyclooxygenase metabolites contribute to the endothelin-1 afferent arteriolar vasoconstrictor and calcium responses Hypertension 35 2000 307 312
39. Z.M. Chu, K.D. Croft, D.A. Kingsbury, J.R. Falck, K.M. Reddy, and L.J. Beilin Cytochrome P450 metabolites of arachidonic acid may be important mediators in angiotensin II-induced vasoconstriction in the rat mesentery in vivo Clin. Sci. (Colch) 98 2000 277 282